cyfluthrin has been researched along with Streptococcal Infections in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Green, K; Low, DE; McGeer, A; Patel, SN; Pillai, DR; Pong-Porter, S | 1 |
Almaraz, F; Baquero, F; Cantón, R; del Campo, R; Loza, E; Morosini, MI | 1 |
Alder, JD; Ewing, P; Flamm, RK; Hernandez, L; Jarvis, K; Ma, Z; Meulbroek, J; Mitten, MJ; Mollison, K; Nilius, AM; Nukkala, M; Oleksijew, A; Or, YS; Paige, L; Tovcimak, A | 1 |
3 other study(ies) available for cyfluthrin and Streptococcal Infections
Article | Year |
---|---|
In vitro activity of ceftaroline, ceftobiprole and cethromycin against clinical isolates of Streptococcus pneumoniae collected from across Canada between 2003 and 2008.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Canada; Ceftaroline; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Ketolides; Male; Microbial Sensitivity Tests; Middle Aged; Streptococcal Infections; Streptococcus pneumoniae; Young Adult | 2009 |
Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin.
Topics: Anti-Bacterial Agents; Drug Resistance; Erythromycin; Genes, Bacterial; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Spain; Streptococcal Infections; Streptococcus pyogenes | 2003 |
Efficacies of ABT-773, a new ketolide, against experimental bacterial infections.
Topics: Animals; Bacterial Infections; Disease Models, Animal; Drug Resistance, Microbial; Erythromycin; Female; Haemophilus Infections; Haemophilus influenzae; Ketolides; Listeriosis; Lung Diseases; Male; Mice; Rats; Rats, Sprague-Dawley; Respiratory Tract Diseases; Staphylococcal Infections; Streptococcal Infections; Streptococcus pneumoniae; Treatment Outcome | 2001 |